---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-013888"
form_type: "8-K"
ticker: "AQST"
cik: "0001398733"
company_name: "Aquestive Therapeutics, Inc."
filed_at: "2024-04-01T23:59:59+00:00"
generated_at: "2026-06-04T04:25:20.593727+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Aquestive appoints Abigail L. Jenkins to Board of Directors

## Summary
- Ms. Jenkins appointed as Class II director effective April 1, 2024, term through 2026 annual meeting.
- Appointed to Nominating and Corporate Governance Committee; board size increased from 7 to 8 members.
- Ms. Jenkins will receive 57,000 stock options under 2018 Equity Incentive Plan, vesting in 1/3 annual increments.
- Board determined Ms. Jenkins is an independent director under Nasdaq rules.

## SEC filing metadata
- accession: 0001628280-24-013888
- form_type: 8-K
- ticker: AQST
- cik: 0001398733
- company_name: Aquestive Therapeutics, Inc.
- filed_at: 2024-04-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1398733/000162828024013888/0001628280-24-013888-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1398733/000162828024013888/aqst-20240401.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-013888
- JSON: https://secwatch.observer/filing/0001628280-24-013888.json
- Plain text: https://secwatch.observer/filing/0001628280-24-013888.txt

## Key facts
- Executive change
  Abigail L. Jenkins was appointed as Director at Aquestive Therapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: On April 1,2024, Aquestive Therapeutics, Inc. (the “Company”) announced the appointment of Abigail L. Jenkins to the Board of Directors of the Company (the “Board”), effective April 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1398733/000162828024013888/0001628280-24-013888-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.